| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 10/05/2006 | US20060223778 Circular nucleic acid vectors, and methods for making and using the same |
| 10/05/2006 | US20060223777 Highly functional short hairpin RNA |
| 10/05/2006 | US20060223776 Crosslinking compound releasing drug in acidity environment; for use as vaccines or therapeutic agents |
| 10/05/2006 | US20060223775 Nucleotide sequence for treating cancer and infection |
| 10/05/2006 | US20060223774 therapy for bacteria infections which ar drug resistance, antibiotic resistance; anticancer agents; hybrid nucleic acid |
| 10/05/2006 | US20060223773 RNAi-mediated inhibition of Frizzled Related Protein-1 for treatment of glaucoma |
| 10/05/2006 | US20060223772 Vectors comprising guinea pig CMV regulatory elements |
| 10/05/2006 | US20060223771 Nuclear factor kappaB inducing factor |
| 10/05/2006 | US20060223770 IRNA agents targeting VEGF |
| 10/05/2006 | US20060223769 Vaccines using nucleic acid-lipid complexes |
| 10/05/2006 | US20060223768 Regulation of gene expression |
| 10/05/2006 | US20060223767 Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene therapy |
| 10/05/2006 | US20060223757 Applications in gene therapy, transgenic organisms, functional genomics, and other areas of cell and molecular biology. |
| 10/05/2006 | US20060223756 Endothelial cell specifically binding peptides |
| 10/05/2006 | US20060223755 biodrug having affinity to bacterial and fungal toxins, and especially to lipopolysaccharide or lipoteichoic acid; treating a fungal or bacterial infection; ear infection, upper respiratory infection, sinusitis, otitis |
| 10/05/2006 | US20060223749 Administering an RNA interference molecule targeting SH2-domain containing inositol 5-phosphatase (SHIP)to increase the number of hematopoietic stem cells in the peripheral blood; transplant rejection of stem cells from bonemarrow controlled; anticarcinogenic agents; automimmune diseases |
| 10/05/2006 | US20060223742 administering pathogen specific antigen and double-stranded ribonucleic acids (dsRNAs), and polyriboinosinic-polyribocytidylic acid stabilized with polylysine and carboxymethylcellulose (poly-ICLC) |
| 10/05/2006 | US20060223741 of neuropathic pain comprising administering angiotensin II receptor 2 (AT2 receptor) antagonists such as 2-(Diphenylacetyl)-5-benzyloxy-6-methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid |
| 10/05/2006 | US20060223144 Method for mass production of human pollicle stimulating hormone |
| 10/05/2006 | US20060223143 Methods and compositions for polypeptide engineering |
| 10/05/2006 | US20060223063 Method of diagnosis of type 2 diabetes and early onset thereof |
| 10/05/2006 | US20060222696 comprising one or more phosphatidylcholines, an N-( omega )-dicarboxylic acid-derivatized phosphatidyl ethanolamine, a targeting factor-modified N-( omega )-dicarboxylic acid-derivatized phosphatidyl ethanolamine, an encapsulated drug, cholesterol; cancer treatment |
| 10/05/2006 | US20060222677 Method of protecting sensitive molecules from a photo-polymerizing environment |
| 10/05/2006 | US20060222666 Clostridial toxin derivatives and methods for treating pain |
| 10/05/2006 | US20060222665 Virus vaccine |
| 10/05/2006 | US20060222663 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 10/05/2006 | US20060222661 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 10/05/2006 | US20060222660 Use of DNA vaccine in combination with a conventional vaccine to overcome immunogen interference |
| 10/05/2006 | US20060222647 Methods and compositions for modulating the activity of PDE5 |
| 10/05/2006 | US20060222636 Compositions, methods and kits relating to reprogramming adult differentiated cells and production of embryonic stem cell-like cells |
| 10/05/2006 | US20060222635 Methods and compositions for selecting cells with increased potency |
| 10/05/2006 | US20060222633 Prevention, decrease, and/or treatment of immunoreactivity by depleting and/or inactivating antigen presenting cells in the host |
| 10/05/2006 | US20060222631 Methods for therapeutic use of brain derived neurotrophic factor in the entorhinal cortex |
| 10/05/2006 | US20060222630 Internal ribosome entry site of the labial gene for protein expression |
| 10/05/2006 | US20060222629 Compositions and methods for delivery of genetic material |
| 10/05/2006 | DE102005013846A1 Identifizierung von Oberflächen-assoziierten Antigenen für die Tumordiagnose und -therapie Identifying surface-associated antigens for tumor diagnosis and therapy |
| 10/05/2006 | CA2603325A1 Methods for lowering the level of tumor necrosis factor (tnf) in tnf-associated disorders |
| 10/05/2006 | CA2603052A1 Immunogenic egfr peptides comprising foreign t cell stimulating epitope |
| 10/04/2006 | EP1707631A2 An improved method for the production and purification of adenoviral vectors |
| 10/04/2006 | EP1707630A1 Antisense oligonucleotide having anticancerous activity |
| 10/04/2006 | EP1707622A1 Use of compounds that regulate hdac6 tubulin deacetylase activity in the preparation of pharmaceutical compositions, method of identifying the aforementioned regulating compounds, said pharmaceutical compounds and applications thereof |
| 10/04/2006 | EP1707214A1 Antagonists of HMG1 for treating inflammatory conditions and the use of HMG1 for effecting weightloss or treating obesity |
| 10/04/2006 | EP1707193A2 Pharmaceutical composition for the prophylaxis and/or treatment of viral diseases |
| 10/04/2006 | EP1706499A2 Human cytomegalovirus us3 gene promoter |
| 10/04/2006 | EP1706492A2 Materials and methods relating to cell cycle control |
| 10/04/2006 | EP1706489A1 Oligomeric compounds for the modulation of bcl-2 |
| 10/04/2006 | EP1706153A1 Minimal lentiviral vector system |
| 10/04/2006 | EP1706151A2 Method of protecting sensitive molecules from a photopolymerising environment |
| 10/04/2006 | EP1706149A2 Liposome composition for delivery of therapeutic agents |
| 10/04/2006 | EP1706140A1 Methods for tailoring the immune response to an antigen or immunogen |
| 10/04/2006 | EP1706139A2 Lysyl oxidase-like 1 (loxl1) and elastogenesis |
| 10/04/2006 | EP1644496A4 Modified vectors for organelle transfection |
| 10/04/2006 | EP1534658A4 Ketone ligands for modulating the expression of exogenous genes via an ecdysone receptor complex |
| 10/04/2006 | EP1311691B1 Method and compositions for promoting osteogenesis |
| 10/04/2006 | EP1255827B1 Oligonucleotides and their use for modulating the expression of tyrosinase involved in the synthesis of melanic pigments |
| 10/04/2006 | EP1135513B1 Adenovirus-mediated gene therapy |
| 10/04/2006 | EP1054955B1 Compositions comprising viruses and methods for concentrating virus preparations |
| 10/04/2006 | EP1003861B1 Mammalian cell membrane proteins; related reagents |
| 10/04/2006 | EP0689601B1 Production of high titer helper-free retroviruses by transient transfection |
| 10/04/2006 | CN1842349A Gene therapy for skin diseases using needle free syringe |
| 10/04/2006 | CN1842346A Regulation of the cytotoxic lymphocyte response by macrophage migration inhibitory factor |
| 10/04/2006 | CN1840706A Small interfering RNA and single-wall carbon nanotube composite and preparation process and use thereof |
| 10/04/2006 | CN1840665A Virulence genes, proteins, and their use |
| 10/04/2006 | CN1840659A Method of treating endotoxemia |
| 10/04/2006 | CN1840204A Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 10/04/2006 | CN1840203A Oligonucleotide drug for preventing and treating influenza virus infection |
| 10/04/2006 | CN1840202A DNA vaccine for preventing haemonchus contortus disease of ruminant |
| 10/04/2006 | CN1277926C Hepatitis B virus gene siRNA sequence and its use |
| 10/03/2006 | US7115728 Adipocyte differentiation; obesity |
| 10/03/2006 | US7115712 Which induce proliferation of lymphocytes in presence of wild-type p35 polypeptide subunit of human interleukin-12 |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115583 Microbubble compositions and methods for oligonucleotide delivery |
| 10/03/2006 | US7115582 Useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3 |
| 10/03/2006 | US7115579 Modulation of oligonucleotide CpG-mediated immune stimulation by positional modification of nucleosides |
| 10/03/2006 | US7115418 Methods of proliferating undifferentiated neural cells |
| 10/03/2006 | US7115394 Isolated and/or recombinantly produced polypeptide; use in regulating spermatogenesis, cell differentiation and proliferation |
| 10/03/2006 | US7115392 Polynucleotides encoding human vascular endothelial growth factor 2 |
| 10/03/2006 | US7115390 Connective tissue growth factor fragments and methods and uses thereof |
| 10/03/2006 | US7115372 Detection of modulators of gene transcription inhibition; obtain sample of cells, incubate with modulator, monitor transcription pattern, compare to control, evaluate for transcription inhibition |
| 10/03/2006 | US7115269 Dna vaccines; genetic engineering; eukaroytic gene expression; screening libraries |
| 10/03/2006 | US7115268 Peptides derived from homologous sequences of the family of staphylococcal and streptococcal toxins, which may be polymeric, that provide protection against, or reduce the severity of toxic shock and septic shock from bacterial infections |
| 10/03/2006 | US7115260 Interleukin-1β converting enzyme like apoptotic protease-6 |
| 10/03/2006 | US7115258 Vesicular monoamine transporter gene therapy in parkinson's disease |
| 10/03/2006 | US7115257 Delivering a growth factor to a host having a retinal degenerative disorder by administering an encapsulated ARPE-19 cell genetically engineered to secrete CNTF within a semipermeable membrane, especially by implantation |
| 10/03/2006 | US7115256 Methods of treating schizophrenia |
| 10/03/2006 | CA2254889C A promoter gene for a porcine complement inhibitor |
| 09/28/2006 | WO2006102654A1 Reduction of ophthamologic neovascularization |
| 09/28/2006 | WO2006102643A2 Stably transformed bone marrow-derived cells and uses thereof |
| 09/28/2006 | WO2006102461A2 Influenza therapeutic |
| 09/28/2006 | WO2006102408A2 Methods and compositions for the modulation of immune responses and autoimmune diseases |
| 09/28/2006 | WO2006102272A2 Methods for treating tumors and cancerous tissues |
| 09/28/2006 | WO2006102163A2 Transfection reagents for non-adherent suspension cells |
| 09/28/2006 | WO2006102114A2 Methods of modulating ros production and apoptosis |
| 09/28/2006 | WO2006101841A2 Seneca valley virus based compositions and methods for treating disease |
| 09/28/2006 | WO2006101810A2 Theileria parva dna vaccines |
| 09/28/2006 | WO2006101634A1 Müller cell specific gene therapy |
| 09/28/2006 | WO2006101503A2 Method for screening agents against human prostate disease |
| 09/28/2006 | WO2006101273A1 Prophylactic/therapeutic agent for cancer |
| 09/28/2006 | WO2006101173A1 Preparation comprising microparticles of complex composed of nucleic acid molecule and collagen |
| 09/28/2006 | WO2006100797A1 Method and pharmaceutical composition for treating psoriasis, squamous cell carcinoma and/or parakeratosis by inhibiting expression of squamous cell carcinoma-related antigen |